Boc-O-methyl-L-threonine

Boc-O-methyl-L-threonine is a protected threonine derivative bearing an N-terminal Boc carbamate and an O-methylated side-chain hydroxyl, retaining the L stereochemistry of the amino acid backbone while masking the native side-chain functionality. This structure is commonly used as a building block in peptide synthesis where threonine's reactivity is controlled during assembly, and the O-methyl group helps prevent side-chain participation under standard coupling and deprotection conditions. As an amino acid derivative, it is typically selected when a threonine residue with reduced side-chain hydrogen-bonding reactivity is desired in the resulting peptide or intermediate.

1. Peptide Building Block

Boc-O-methyl-L-threonine is used by peptide chemistry groups to incorporate a threonine-derived residue into custom peptides during both solid-phase and solution-phase assembly workflows. The Boc protection on the amino terminus supports controlled stepwise coupling, while the O-methylated side chain reduces competing side reactions associated with a free threonine hydroxyl, improving reliability in multistep syntheses. Researchers commonly choose this derivative when they need a threonine-like residue that is less prone to side-chain reactivity, helping maintain sequence integrity across iterative coupling cycles.

2. Protected Threonine Analogues

Boc-O-methyl-L-threonine serves as a practical protected analogue for preparing peptide segments and fragment intermediates where threonine's side-chain hydroxyl must be functionally masked. Medicinal chemistry and chemical biology teams often employ such threonine derivatives to tune local polarity and hydrogen-bonding patterns in peptide leads, while keeping synthetic handling straightforward compared with unprotected or differently protected threonines. In downstream workflows, the derivative is valuable for generating defined peptide structures for SAR studies, receptor-binding assays, or stability-focused comparisons where side-chain protection strategy is part of the design space.

3. Pharmaceutical Intermediate Development

Boc-O-methyl-L-threonine is also used as an intermediate in the development of peptide-like building blocks and specialty fragments for pharmaceutical research programs. Process and development chemists value the protected, single-residue format because it can be integrated into larger synthetic sequences with predictable functional-group availability, supporting scalable manufacturing routes for peptide intermediates. The combination of Boc N-protection and O-methyl side-chain masking makes it a useful starting material when the target intermediate requires a controlled threonine motif without free hydroxyl reactivity during key synthetic steps.

4. Fragment Coupling Chemistry

Boc-O-methyl-L-threonine is frequently selected for segment condensation and fragment coupling strategies where threonine residues must be introduced with minimized side-chain interference. In custom peptide manufacturing and academic core facilities, the derivative provides a controlled stereochemical threonine unit that aligns with established peptide assembly practices, enabling efficient incorporation into longer sequences. This use case is especially relevant when the synthesis requires consistent reactivity across multiple residues and when side-chain hydroxyl participation would complicate purification, yield, or product consistency.

1. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L